Carregant...

Immunomodulatory Drugs in the Management of SARS-CoV-2

With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Daniel R. Burrage, Soraya Koushesh, Nidhi Sofat
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020-08-01
Col·lecció:Frontiers in Immunology
Matèries:
Accés en línia:https://www.frontiersin.org/article/10.3389/fimmu.2020.01844/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!